ERBB2 and cancer: Comparison of the expression levels ofthe transcript in TNBC and HER2-enriched breast cancer cells revealed MALAT1overexpression in triplenegative cancer cells, which may be an indication thatMALAT1 expression is correlated with the metastatic ability and that thedifferences are associated with the mediated participation of MALAT1 indifferent cellular processes [2].